Engage the Companies Driving Neoantigen Therapies Into the Clinic
The neoantigen field is entering a critical phase, with more programmes progressing into the clinic and teams actively seeking partners to drive success. From sequencing and validation to peptide development, assays, and manufacturing, the demand for proven external expertise has never been greater.
This is where you come in.
At the 9th International Neoantigen Summit, position your organisation at the centre of neoantigen drug development by engaging directly with the companies advancing these therapies and evaluating external partners.
Across 3 focused days, this is the only dedicated meeting bringing together the full neoantigen biopharma ecosystem in one room, giving you a uniquely concentrated opportunity to connect with decision-makers.
This is your single annual touchpoint to meet C-level executives, clinical leaders and scientists, all with a shared goal: finding the right partners to move their therapies into and through the clinic.
Why This Year Matters Now?
Clinical data is reshaping confidence in neoantigen therapies
More programmes are entering trials and requiring external partners
The industry is actively reassessing strategies and suppliers
What to Expect?
Meet New Clients
Expand your client base by networking face-to-face with dedicated attendees actively seeking solutions to overcome their drug development challenges.
Centre Yourself in Biopharma Dealmaking
Position your brand in front of C-Level decision-makers by showcasing your company logo on event materials including our website, brochure, and on-site signage.
Demonstrate Your Expertise
Present your work within one of our focused tracks, participate in a panel discussion or showcase your solutions in a bespoke exhibition booth to demonstrate your company's unique capabilities.
Gain Market Intelligence
Stay ahead of industry trends by hearing directly from KOLs. Gain insights and competitor strategies to shape your organization’s future and sharpen its competitive edge.
Where You Fit
Our attendees from the global neoantigen community are looking for service and solution providers with capabilities in the below areas but not limited to:
- CDMOs/CMO that can provide streamlined manufacturing services
- CROs that can help with preclinical studies and navigate clinical trial set up and development
- Assays & Testing Services to help assess immunogenicity and support scientific research
- RNA, whole exome sequencing and bioinformatics to help prediction of neoantigen targets
- Peptide services to cover the neoantigen peptide life cycle from early screening to synthesis and clinical development
Hear What Our Past Sponsors Have to Say
The event includes the "who's who" of the PCT world.
Mark Thornber, Director, Biopharma Business Development Sales, Personalis
Interesting talks, good discussions. Always interesting to connect with your colleagues in other companies.
Christian Thygesen, Business Development Specialist, NEC Bio
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Available Inventory
We have a range of inventory from standard booth and speaking slots to more bespoke deliverables, such as badges, exclusive dinners and tours to help elevate your brand.
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Jack Waring
Partnerships Director
9th International Neoantigen Summit